New Urocit K Formulation Introduced

Share this content:

Mission Pharmacal Company has introduced the Urocit-K 15 mEq (potassium citrate) extended-release tablet.

Urocit-K is a urine alkalizing agent used to prevent certain types of kidney stones.

The new formulation, which uses a wax-matrix delivery system to allow for extended-release of potassium citrate, provides a higher concentration of potassium citrate and has more active ingredient per tablet than other Urocit-K formulations, such as Urocit-K 10 mEq and Urocit-K 5 mEq, the company said.

You must be a registered member of Renal and Urology News to post a comment.